in the vaccination group, the researchers looked separately at the risk of myocarditis for a range of covid-19 vaccines, including mrna vaccines from pfizer-biontech and moderna, as well as, novavax’s nuvaxovid, astrazeneca’s vaxzevria, and johnson & johnson’s janssen.
the researchers also found that 61 per cent of people diagnosed with myocarditis after having covid-19 or receiving the vaccine were men. of the people who were diagnosed with myocarditis in both the vaccination and covid-19 groups, 1.07 per cent were hospitalized and 0.015 per cent died.
“covid-19 infection and the related vaccines both pose a risk for myocarditis. however, the relative risk of heart inflammation induced by covid-19 infection is substantially greater than the risk posed by the vaccines,” lead author dr. paddy ssentongo said in the news release. “we hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake.”
the researchers note that while vaccines have been shown to reduce severe covid-19 symptoms, heart complications have been linked with mrna covid-19 vaccination, with myocarditis in teenage boys a primary concern. and though a recent study out of israel,
published in the american heart association journal circulation, found the risk of developing myocarditis from a booster dose of the pfizer covid-19 vaccine to be low, the risk was highest for teen boys and young men.